# FDA Inspection 825387 - Baltimore Washington Medical Center - March 27, 2013

Source: https://www.keypedia.com/records/fda_inspections/baltimore-washington-medical-center/275136b8-86e5-4f59-830d-38852810f73f
Source feed: FDA_Inspections

> FDA Inspection 825387 for Baltimore Washington Medical Center on March 27, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 825387
- Company Name: Baltimore Washington Medical Center
- Inspection Date: 2013-03-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 719819 - 2011-04-07](https://www.keypedia.com/records/fda_inspections/baltimore-washington-medical-center/49b3cfdd-6c32-4055-b625-568f8dc63964)
- [FDA Inspection 610385 - 2009-08-31](https://www.keypedia.com/records/fda_inspections/baltimore-washington-medical-center/192467cc-b8a8-4650-9de5-5efa742b3902)

Company: https://www.keypedia.com/companies/baltimore-washington-medical-center/3233ee06-970c-436e-b3c1-f79faf563342

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d